New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 25, 2014
08:47 EDTSRNESorrento Therapeutics and Morphotek sign drug development agreement
Sorrento Therapeutics subsidiary Concortis Biosystems announced a collaboration to generate novel antibody drug conjugates based on a Morphotek antibody linked to chemotherapeutic agents using Concortis' proprietary ADC Technology. Under the terms of the agreement, Sorrento will receive research fees, up-front payment, milestone payments and royalties on future net sales. Sorrento has the potential to receive up to $50M upon successful attainment of key milestones.
News For SRNE From The Last 14 Days
Check below for free stories on SRNE the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 31, 2014
17:41 EDTSRNESorrento Therapeutics announces unexpected death of Chief Business Officer
Sorrento Therapeutics announced the death of Amar Singh, Chief Business Officer and executive VP. Singh died suddenly and unexpectedly of apparent natural causes on July 30.
July 21, 2014
08:47 EDTSRNESorrento Therapeutics receives funding for development of Myc inhibitor
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use